Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
16.92
+0.24 (1.44%)
Oct 9, 2025, 4:00 PM EDT - Market closed

Zymeworks Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
122.8776.376.01412.4826.6838.95
Revenue Growth (YoY)
95.95%0.38%-81.57%1446.03%-31.50%-
Gross Profit
122.8776.376.01412.4826.6838.95
Selling, General & Admin
61.9761.5170.4573.3642.5655.22
Research & Development
143.6134.62143.62208.6199.75171.2
Other Operating Expenses
-17.29----
Total Operating Expenses
205.58213.41214.07281.95242.31226.42
Operating Income
-82.71-137.11-138.05130.53-215.63-187.47
Interest Income
15.7219.9419.713.61.975.7
Other Non-Operating Income (Expense)
-0.430.56-0.891.111.311.65
Total Non-Operating Income (Expense)
15.2920.518.814.713.277.35
Pretax Income
-67.42-116.61-119.24135.23-212.36-180.12
Provision for Income Taxes
-6.25-6.080.57-10.890.52-0.43
Net Income
-73.68-122.7-118.67124.34-211.84-179.69
Net Income to Common
-73.68-122.7-118.67124.34-211.84-179.69
Shares Outstanding (Basic)
757669655250
Shares Outstanding (Diluted)
767669655250
Shares Change (YoY)
3.21%10.19%5.54%25.16%3.47%-
EPS (Basic)
-0.98-1.62-1.721.91-4.11-3.58
EPS (Diluted)
-0.98-1.62-1.721.90-4.61-3.58
Free Cash Flow
-40.45-112.04-120.78135.96-204.86-155.71
Free Cash Flow Per Share
-0.53-1.48-1.752.08-3.93-3.09
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-67.32%-179.69%-181.62%31.64%-808.22%-481.29%
Profit Margin
-49.79%-144.85%-157.62%35.43%-797.88%-461.33%
FCF Margin
-32.92%-146.83%-158.89%32.96%-767.82%-399.77%
EBITDA
-69.84-125.92-120.75142.53-206.05-177.19
EBITDA Margin
-56.84%-165.02%-158.85%34.55%-772.30%-454.90%
EBIT
-82.71-137.11-138.05130.53-215.63-187.47
EBIT Margin
-67.32%-179.69%-181.62%31.64%-808.22%-481.29%
Effective Tax Rate
9.27%5.22%-0.48%-8.05%-0.24%0.24%
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q